Management of risk factors for gastrointestinal bleeding in patients receiving anticoagulant therapy
Direct oral anticoagulants (DOACs) are used to prevent and treat thrombosis and thromboembolic events in patients with various diseases. Despite its high efficacy and safety, DOAC therapy is accompanied by increased risk of hemorrhage, including gastrointestinal bleeding. Bleeding risk depends on in...
Saved in:
Main Authors: | N. V. Bakulina, S. V. Tikhonov, N. B. Lishchuk, A. B. Karaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2021-09-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/4635 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding
by: A. B. Sumarokov, et al.
Published: (2019-01-01) -
Anticoagulant-related bleeding in patients with heart failure in combination with chronic obstructive pulmonary disease and atrial fibrillation. Experience with Idarucizumab
by: L. A. Shpagina, et al.
Published: (2020-06-01) -
Gastrointestinal Bleeding: a Cardiologist's Point of View
by: O. V. Averkov, et al.
Published: (2021-11-01) -
Prevention of gastrointestinal bleeding in patients receiving oral anticoagulants: focus on proton pump inhibitors
by: O. D. Ostroumova, et al.
Published: (2019-11-01) -
Complications of Pharmacotherapy with New Oral Anticoagulants Caused by Inter-Drug Interactions: Focus on Gastrointestinal Bleeding
by: A. P. Pereverzev, et al.
Published: (2019-06-01)